The cost-effectiveness of voluntary intrapartum rapid human immunodeficiency virus testing for women without adequate prenatal care

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 5 I, 1999, Pages 1062-1071

  Grobman, W A ^a   Garcia, P M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Decision analysis; Human immunodeficiency virus; Human immunodeficiency virus testing; Perinatal transmission

Indexed keywords

ZIDOVUDINE;

CONFERENCE PAPER; COST; COST CONTROL; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOBLOTTING; INTRAUTERINE INFECTION; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; VERTICAL TRANSMISSION;

EID: 0032714573     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70082-7     Document Type: Conference Paper

References (41)

1. EM Connor RS Sperling R Gelber P Kiselev G Scott MJ O’Sullivan Reduction of maternal—infant transmission of human immunodeficiency virus type 1 with zidovudine treatment N Engl J Med 331 1994 1173 1180
2. Centers for Disease Control and Prevention Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women MMWR Morb Mortal Wkly Rep 44 1995 1 15
3. JA Mauskopf JE Paul DS Wichman AD White HH. Tilson Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine JAMA 276 1996 132 138
4. ER Myers JW Thompson K. Simpson Cost-effectiveness of mandatory compared with voluntary screening for human immunodeficiency virus in pregnancy Obstet Gynecol 91 1998 174 181
5. RD Gorsky PG Farnham WL Straus B Caldwell DR Holtgrave RJ Simonds Preventing perinatal transmission of HIV—Costs and effectiveness of a recommended intervention Public Health Rep 111 1996 335 341
6. JL. Ecker The cost-effectiveness of human immunodeficiency virus screening in pregnancy Am J Obstet Gynecol 174 1996 716 721
7. Centers for Disease Control and Prevention Success in implementing Public Health Service guidelines to reduce perinatal transmission of HIV—Louisinana, Michigan, New Jersey, and South Carolina, 1993, 1995, 1996 MMWR Morb Mortal Wkly Rep 47 1998 688 691
8. Centers for Disease Control and Prevention Update: HIV counseling and testing using rapid test—United States, 1995 MMWR Morb Mortal Wkly Rep 47 1998 211 215
9. Centers for Disease Control and Prevention Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission—Thailand, 1996-1998 MMWR Morb Mortal Wkly Rep 47 1998 151 154
10. N Wade G Birkhead B Warren T Charnonneau P French L Wang Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus N Engl J Med 339 1998 1409 1414
11. MD Kogan JA Martin GR Alexander M Kotelchuck SJ Ventura FD. Frigoletto The changing pattern of prenatal care utilization in the United States, 1981-1995, using different prenatal care indices JAMA 279 1998 1623 1628
12. BJ Turner LJ McKee NS Silverman WW Hauck TR Fanning LE. Markson Prenatal care and birth outcomes of a cohort of HIV-infected women J Acquir Immune Defic Syndr 12 1996 259 267
13. HL Minkoff S McCalla J. Feldman The relationship of cocaine use to syphilis and HIV infection among inner city parturient women Am J Obstet Gynecol 163 1990 521 526
14. MK Lindsay TI Feng HB Peterson BA Slade S Willis L. Klein Routine human immunodeficiency virus infection screening in unregistered and registered inner-city parturients Obstet Gynecol 77 1991 599 603
15. H Minkoff MJ. O’Sullivan The case for rapid HIV testing during labor JAMA 279 1998 1743 1744
16. W Cozen L Mascola R Enguidanos S Bauch M Giles P Paxton Screening for HIV and hepatitis B virus in Los Angeles county prenatal clinics: a demonstration project J Acquir Immune Defic Syndr 6 1993 95 98
17. Barbacci M, Repke JT, Chaisson RE. Routine screening for HIV infection. Lancet 991;337:709-11.
18. C Healton S Taylor C Burr A Dumois N Loewenstein J. Kaye The impact of patient education about the effect of zidovudine on HIV perinatal transmission: knowledge gain, attitudes, and behavioral intent among women with and at risk of HIV Am J Prev Med 12 Suppl 1996 47 52
19. AA Wiznia M Crane G Lambert J Sansary A Harris L. Solomon Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical center JAMA 275 1996 1504 1506
20. WJ Kassler BA Dillon C Haley W Jones A. Goldman On-site rapid HIV testing with same-day results and counseling AIDS 11 1197 1045 1051
21. PG Farnham RD Gorsky DR Holtgrave WK Jones ME. Guinan Counseling and testing for HIV prevention: costs, effects and cost-effectiveness of more rapid screening tests Public Health Rep 111 1996 44 53
22. K Irwin N Olivo CA Schable JT Weber R Janssen J. Ernst Performance characteristics of a rapid HIV antibody assay in a hospital with a high prevalence of HIV infection Ann Intern Med 125 1996 471 475
23. DT Dunn ML Newell AE Ades CS. Peckham Risk of human immunodeficiency virus type 1 transmission through breastfeeding Lancet 340 1992 585 588
24. LK Grossman JB Larsen-Alexander SM Fitzsimmons L. Cordero Breastfeeding among low-income women Clin Pediatr 28 1989 38 42
25. DM Gibb SE MacDonagh PA Tookey T Duong A Nicoll DJ Goldberg Uptake of interventions to reduce mother-to-child transmission of HIV in the United Kingdom and Ireland AIDS 11 1997 F53 F58
26. G Mansergh AC Haddix RW Steketee PI Nieburg DJ Hu RJ Simonds Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African developing country setting JAMA 276 1996 139 145
27. Drug Topic Redbook, 1998 1998 Medical Economics Company Montvale (NJ)
28. DC Hsia JA Fleishman JA East FJ. Hellinger Pediatric human immunodeficiency virus infection Arch Pediatr Adolesc Med 149 1995 489 496
29. HX Barnhart MB Caldwell P Thomas L Mascola I Ortiz H Hsu Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the pediatric spectrum of disease project Pediatrics 97 1996 710 716
30. KA Phillips RA Lowe JG Kahn P Lurie AL Avins D. Ciccarone The cost-effectiveness of HIV testing of physicians and dentists in the United States JAMA 271 1994 851 858
31. Centers for Disease Control and Prevention Update: AIDS among women—United States, 1994 MMWR Morb Mortal Wkly Rep 44 1995 81 84
32. RE Bawdon S Sobhi J. Dax The transfer of anti-human immunodeficiency virus nucleoside compounds by the term human placenta Am J Obstet Gynecol 167 1992 1570 1574
33. MJ O’Sullivan PJ Boyer GB Scott WP Parks S Weller MR Blum The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study Am J Obstet Gynecol 168 1993 1510 1516
34. L Mandelbrot J Le Chenadec A Berrebi A Bongain JL Benifla JF Delfraissy Interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort JAMA 280 1998 55 60
35. DT Dunn CD Brandt A Krivine SA Cassol P Roques W Borkowsky The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission AIDS 9 1995 F7 F11
36. C Rouzioux D Costagliola M Burgard S Blanche MJ Mayaux C Griscelli Estimated timing of mother-to-child human immunodeficiency virus type 1 transmission by use of a Markov model Am J Epidemiol 142 1995 1330 1337
37. A Ehrnst S Lindgre M Dictor B Johansson A Sonnerborg J Czajkowski HIV in pregnant women and their offspring: evidence of late transmission Lancet 338 1991 203 207
38. Centers for Disease Control and Prevention Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee MMWR Morb Mortal Wkly Rep 30 1991 1 24
39. SJ Ventura KD Peters JA Martin JD. Maurer Births and deaths: United States, 1996 Mo Vital Stat Rep 46 1997 1 40
40. T Tengs ME Adams JS Pliskin DG Safran JE Siegel MC Weinstein Five hundred life saving interventions and their cost-effectiveness Risk Analysis 15 1995 369 390
41. J. Rips Establishing a successful HIV counseling and testing service Obstet Gynecol Clin 24 1997 873 889